LakeShore Gross Profit from 2010 to 2024

LSBPW Stock

0.04 0 3.90%

LakeShore Biopharma Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about 432.5 M in 2024. Gross Profit is the profit LakeShore Biopharma Co, makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

455.7 M

Current Value

432.5 M

Quarterly Volatility

120 M

Credit Downgrade

Yuan Drop

Covid

Check LakeShore Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LakeShore Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.9 M, Interest Expense of 29.6 M or Selling General Administrative of 130.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Ptb Ratio of 0.0 or Days Sales Outstanding of 304. LakeShore financial statements analysis is a perfect complement when working with LakeShore Biopharma Valuation or Volatility modules.

Check out the analysis of LakeShore Biopharma Correlation against competitors.

Latest LakeShore Biopharma's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of LakeShore Biopharma Co, over the last few years. Gross profit is a required income statement account that reflects total revenue of LakeShore Biopharma Co, minus its cost of goods sold. It is profit before LakeShore Biopharma operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. LakeShore Biopharma's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LakeShore Biopharma's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

LakeShore Gross Profit Regression Statistics

	Arithmetic Mean	265,261,859
	Geometric Mean	245,712,675
	Coefficient Of Variation	45.24
	Mean Deviation	99,590,784
	Median	197,359,052
	Standard Deviation	120,017,154
	Sample Variance	14404.1T
	Range	336.5M
	R-Value	0.75
	Mean Square Error	6795.3T
	R-Squared	0.56
	Significance	0
	Slope	20,117,450
	Total Sum of Squares	201657.6T

LakeShore Gross Profit History

	2024	432.5 M
	2023	455.7 M
	2022	533.8 M
	2021	385.9 M

Other Fundumenentals of LakeShore Biopharma Co,

Gross Profit Margin

LakeShore Biopharma Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Short Long Term Debt
Total Assets		0.88	-0.13	0.96	-0.87	0.96	0.93	0.96	-0.69	0.94	0.96	0.65	-0.68	0.89	-0.79	0.65	0.76
Total Stockholder Equity	0.88		-0.39	0.8	-0.9	0.94	0.64	0.95	-0.95	0.99	0.96	0.79	-0.7	0.87	-0.83	0.79	0.89
Current Deferred Revenue	-0.13	-0.39		-0.19	0.55	-0.12	0.14	-0.19	0.42	-0.33	-0.2	-0.42	0.65	-0.22	0.7	-0.42	-0.46
Net Debt	0.96	0.8	-0.19		-0.9	0.9	0.9	0.93	-0.59	0.88	0.85	0.72	-0.81	0.93	-0.83	0.72	0.8
Retained Earnings	-0.87	-0.9	0.55	-0.9		-0.86	-0.66	-0.91	0.78	-0.93	-0.85	-0.86	0.93	-0.92	0.97	-0.86	-0.93
Accounts Payable	0.96	0.94	-0.12	0.9	-0.86		0.81	0.99	-0.83	0.97	0.97	0.77	-0.65	0.93	-0.74	0.77	0.85
Long Term Debt	0.93	0.64	0.14	0.9	-0.66	0.81		0.81	-0.38	0.75	0.8	0.38	-0.48	0.72	-0.58	0.38	0.49
Net Receivables	0.96	0.95	-0.19	0.93	-0.91	0.99	0.81		-0.83	0.98	0.97	0.81	-0.73	0.96	-0.8	0.81	0.89
Total Liab	-0.69	-0.95	0.42	-0.59	0.78	-0.83	-0.38	-0.83		-0.89	-0.85	-0.8	0.58	-0.76	0.7	-0.8	-0.87
Net Invested Capital	0.94	0.99	-0.33	0.88	-0.93	0.97	0.75	0.98	-0.89		0.98	0.79	-0.74	0.91	-0.85	0.79	0.89
Total Current Assets	0.96	0.96	-0.2	0.85	-0.85	0.97	0.8	0.97	-0.85	0.98		0.67	-0.61	0.85	-0.77	0.67	0.79
Capital Stock	0.65	0.79	-0.42	0.72	-0.86	0.77	0.38	0.81	-0.8	0.79	0.67		-0.84	0.91	-0.75	1.0	0.98
Net Working Capital	-0.68	-0.7	0.65	-0.81	0.93	-0.65	-0.48	-0.73	0.58	-0.74	-0.61	-0.84		-0.83	0.93	-0.84	-0.87
Short Term Debt	0.89	0.87	-0.22	0.93	-0.92	0.93	0.72	0.96	-0.76	0.91	0.85	0.91	-0.83		-0.8	0.91	0.94
Intangible Assets	-0.79	-0.83	0.7	-0.83	0.97	-0.74	-0.58	-0.8	0.7	-0.85	-0.77	-0.75	0.93	-0.8		-0.75	-0.84
Common Stock	0.65	0.79	-0.42	0.72	-0.86	0.77	0.38	0.81	-0.8	0.79	0.67	1.0	-0.84	0.91	-0.75		0.98
Short Long Term Debt	0.76	0.89	-0.46	0.8	-0.93	0.85	0.49	0.89	-0.87	0.89	0.79	0.98	-0.87	0.94	-0.84	0.98

Click cells to compare fundamentals

About LakeShore Biopharma Financial Statements

LakeShore Biopharma investors use historical fundamental indicators, such as LakeShore Biopharma's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LakeShore Biopharma. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	455.7 M	432.5 M
Gross Profit Margin	0.79	0.62

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for LakeShore Stock Analysis

When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC